Nathan Rich
Stock Analyst at Goldman Sachs
(1.30)
# 2,549
Out of 4,412 analysts
76
Total ratings
33.9%
Success rate
-11.08%
Average return
Main Sectors:
17 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Maintains: Buy | $450 → $385 | $305.90 | +25.86% | 7 | Apr 3, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $5.5 → $6.25 | $5.87 | +6.47% | 6 | Mar 4, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $13.26 | +5.58% | 9 | Feb 27, 2024 | |
| OSCR Oscar Health | Maintains: Neutral | $8 → $16 | $17.56 | -8.88% | 5 | Feb 9, 2024 | |
| TEVA Teva Pharmaceutical | Maintains: Neutral | $10 → $11 | $13.81 | -20.35% | 4 | Feb 5, 2024 | |
| ZTS Zoetis | Maintains: Buy | $190 → $226 | $158.42 | +42.66% | 6 | Jan 17, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $499.30 | +30.18% | 3 | Jan 17, 2024 | |
| PDCO Patterson Companies | Maintains: Neutral | $35 → $30 | $25.77 | +16.41% | 4 | Dec 1, 2023 | |
| SONX Sonendo | Maintains: Buy | $1.75 → $1.5 | $0.10 | +1,462.50% | 8 | Nov 10, 2023 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $42 → $36 | $30.57 | +17.76% | 7 | Nov 7, 2023 | |
| NVST Envista Holdings | Maintains: Buy | $41 → $28 | $20.39 | +37.32% | 2 | Nov 3, 2023 | |
| CVS CVS Health | Maintains: Buy | $100 → $88 | $67.18 | +30.99% | 3 | May 4, 2023 | |
| ALHC Alignment Healthcare | Maintains: Buy | $14 → $12 | $5.21 | +130.33% | 6 | Apr 19, 2023 | |
| HSIC Henry Schein | Downgrades: Neutral | $93 → $85 | $73.13 | +16.23% | 1 | Jul 21, 2022 | |
| VTRS Viatris | Maintains: Neutral | $10 → $11 | $11.57 | -4.93% | 3 | May 12, 2022 | |
| MOH Molina Healthcare | Initiates: Buy | n/a | $342.23 | - | 1 | Dec 14, 2021 | |
| UNH UnitedHealth Group | Initiates: Buy | n/a | $495.35 | - | 1 | Dec 14, 2021 |
Humana
Apr 3, 2024
Maintains: Buy
Price Target: $450 → $385
Current: $305.90
Upside: +25.86%
Amneal Pharmaceuticals
Mar 4, 2024
Maintains: Buy
Price Target: $5.5 → $6.25
Current: $5.87
Upside: +6.47%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $13.26
Upside: +5.58%
Oscar Health
Feb 9, 2024
Maintains: Neutral
Price Target: $8 → $16
Current: $17.56
Upside: -8.88%
Teva Pharmaceutical
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $13.81
Upside: -20.35%
Zoetis
Jan 17, 2024
Maintains: Buy
Price Target: $190 → $226
Current: $158.42
Upside: +42.66%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $499.30
Upside: +30.18%
Patterson Companies
Dec 1, 2023
Maintains: Neutral
Price Target: $35 → $30
Current: $25.77
Upside: +16.41%
Sonendo
Nov 10, 2023
Maintains: Buy
Price Target: $1.75 → $1.5
Current: $0.10
Upside: +1,462.50%
DENTSPLY SIRONA
Nov 7, 2023
Maintains: Neutral
Price Target: $42 → $36
Current: $30.57
Upside: +17.76%
Envista Holdings
Nov 3, 2023
Maintains: Buy
Price Target: $41 → $28
Current: $20.39
Upside: +37.32%
CVS Health
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $67.18
Upside: +30.99%
Alignment Healthcare
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $5.21
Upside: +130.33%
Henry Schein
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $73.13
Upside: +16.23%
Viatris
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $11.57
Upside: -4.93%
Molina Healthcare
Dec 14, 2021
Initiates: Buy
Price Target: n/a
Current: $342.23
Upside: -
UnitedHealth Group
Dec 14, 2021
Initiates: Buy
Price Target: n/a
Current: $495.35
Upside: -